Vafidemstat | Interleukin Related interleukin-related.com

Product Name :
Vafidemstat

Search keywords :
Vafidemstat

drugId :
null

Target Vo:
Monoamine oxidase B

Target Vo Short Name :
MAOB

Moa_Name:
Lysine-specific histone demethylase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Oryzon Genomics Sa

Active Company_Name :
Oryzon Genomics Sa

Active Indication_Name:
Schizophrenia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-eIF4E (Ser209) Antibody
EEA1 Antibody
MLKL Antibody: MLKL Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to MLKL. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts